‡a
preclinicalcomparisonofthebloodbrainbarrierbbbpermeabilityofosimertinibwithotheregfrtkis
‡A
Preclinical comparison of the blood brain barrier (BBB) permeability of osimertinib with other EGFR TKIs
‡9
1
‡a
targetingofnat10enhanceshealthspaninamousemodelofhumanacceleratedagingsyndrome
‡A
Targeting of NAT10 enhances healthspan in a mouse model of human accelerated aging syndrome.
‡9
1